Products

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
DIACOUSTIC MEDICAL DEVICES (PTY)
Cardiology AI
SensiCardiac Mobi is an FDA-cleared AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.

See all 1 product →

About DIACOUSTIC MEDICAL DEVICES (PTY)

DIACOUSTIC MEDICAL DEVICES (PTY) is a healthcare company based in South Africa, specializing in innovative medical devices. Their primary focus appears to be in cardiac diagnostics, particularly with products like the ‘Sensicardiac Mobi’ and ‘Sensicardiac Mobi Diagnostic Heart Murmur Application’. These devices are designed for clinical care, diagnostic support, and patient-facing applications, aiming to assist healthcare professionals in the detection and analysis of heart murmurs. Given the context of being a ‘healthcare AI company,’ it is highly probable that their solutions leverage artificial intelligence for enhanced diagnostic accuracy and efficiency in interpreting heart and lung sounds. The company’s offerings likely contribute to improving patient outcomes through early and accurate diagnosis in both clinical and potentially remote settings.

Focus Areas

Heart murmur detection AI diagnostics telemedicine digital health virtual care electronic stethoscopes cardiovascular health clinical decision support

Business Intelligence

TechnologyAI-powered Sensi Diagnostic Heart Murmur Algorithm, hosted server environment (Linux OS), mobile application (iPhone 4S or later), compatible electronic stethoscopes (e.g., 3M Littmann 3200)
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Heart Murmur Detection
DIACOUSTIC MEDICAL DEVICES (PTY) specializes in advanced heart murmur detection through its Sensi Diagnostic Heart Murmur Software. This system is designed to acquire, record, and analyze heart sounds, distinguishing between normal/physiological and pathological murmurs.
AI Diagnostics
The company leverages AI-powered algorithms within its Sensi software to analyze acoustic heart signals and ECG data. This diagnostic support aids in the identification and classification of suspected heart murmurs, enhancing clinical assessment.
Electronic Stethoscopes
DIACOUSTIC MEDICAL DEVICES (PTY) offers the Sensi Electronic Stethoscope, which is part of a comprehensive system including specialized software and a WelchAllyn USB Analyzer. These electronic stethoscopes amplify body sounds and convert them into electronic signals for optimal listening and analysis.
Cardiovascular Health
The core mission is to improve cardiovascular health outcomes by providing tools for early and accurate detection of cardiac abnormalities indicated by heart murmurs.
Clinical Decision Support
The Sensi device functions as a clinical decision support system, assisting medical examiners in analyzing cardiac sounds and informing referral decisions. It is intended to aid, not supersede, the judgment of qualified medical personnel.
Physician Tip

For physicians, DIACOUSTIC MEDICAL DEVICES (PTY) offers a significant advantage by augmenting traditional auscultation with objective, AI-assisted analysis of heart sounds and ECG signals. This can lead to enhanced diagnostic accuracy, particularly in distinguishing between benign and pathological murmurs, and supports more informed and timely referral decisions. The ability to record and store objective data provides valuable documentation for patient records, longitudinal monitoring, and collaborative consultations, ultimately improving patient care pathways and potentially reducing diagnostic uncertainty.

The Sensi Diagnostic Heart Murmur Software operates on a Windows operating system. While direct integrations with Electronic Health Record (EHR) or Electronic Medical Record (EMR) systems are not explicitly detailed in the provided information, seamless data exchange with such systems, often via standards like FHIR and HL7, is a critical component for modern digital health solutions to ensure comprehensive patient data management and streamlined clinical workflows.

Products by DIACOUSTIC MEDICAL DEVICES (PTY)

1 product in the directory

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
DIACOUSTIC MEDICAL DEVICES (PTY)
Cardiology AI
SensiCardiac Mobi is an FDA-cleared AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.

What the Web Says

DIACOUSTIC MEDICAL DEVICES (PTY) appears to be a lesser-known company with limited public reviews available on major platforms like G2, Glassdoor, Capterra, or Reddit. Information regarding specific product reviews or detailed employer opinions is scarce, making a comprehensive assessment challenging. The company's primary focus seems to be within the medical device sector, likely in South Africa given the '(PTY)' designation.

Overall: Mixed

Strengths

  • Unknown - insufficient data
  • Potentially specialized in a niche medical device market
  • Could offer local employment opportunities in South Africa

Limitations

  • Limited public visibility and brand recognition
  • Lack of readily available product reviews
  • Scarcity of employer reviews on major platforms (Glassdoor, Reddit)
  • Difficulty in assessing company culture or employee satisfaction
  • Potential for smaller market reach compared to larger competitors

Based on reviews from: G2 (no relevant results), Glassdoor (no relevant results), Capterra (no relevant results), Reddit (no relevant results), General web search (limited information)

Last updated: 2026-07-17

Videos

News, demos, and interviews about DIACOUSTIC MEDICAL DEVICES (PTY).

Loading videos...

Videos load interactively. If none appear, search YouTube for DIACOUSTIC MEDICAL DEVICES (PTY) →

View all on YouTube

Press & Coverage

MD+DI (Medical Device and Diagnostic Industry)
Innovative Medical Devices from Around the Worldu2014Diacoustic Medical Devices
This article from 2015 highlights Diacoustic Medical Devices from South Africa as an innovator in the medical device industry, featuring their SensiCardiac device.
2015-07
NSW Health
$7.4 million investment in ground-breaking medical devices
This press release announces a $7.4 million investment by the Minns Labor Government in four medical technology devices, including an AI-powered system for early warning in pregnancy and childbirth.
2026-05
Avnet
Using sound to capture medical data boosts device innovation - Avnet
This article discusses the rapid development of acoustic technology for continuous health monitoring, with applications in cardiac and fetal monitoring, and the growing market for wearable medical devices.
2024-02
PMC (PubMed Central)
Body Acoustics for the Non-Invasive Diagnosis of Medical Conditions - PMC
This peer-reviewed article reviews advances in non-invasive monitoring methods based on body acoustics for diagnosing various medical conditions, emphasizing the potential of acoustic-based diagnostic solutions.
2022-04
Therapeutic Goods Administration (TGA)
Regulatory decisions and notices (medical devices and IVDs)
This page from the Australian TGA provides regulatory decisions and notices for medical devices and IVDs, including information on compliance actions and changes to requirements.
2025-06
Western Sydney University
$1.3 million awarded to Western researchers for innovative medical device
Western Sydney University researchers received over $1.3 million from the NSW Government's Medical Devices Fund to commercialize their 'Ins&Outs' device for functional bowel disorders.
2026-06
Australian Government Department of Health and Aged Care
$100 million to support Australian medical innovations
The Albanese Government has awarded nearly $100 million in funding to three organizations to commercialize emerging Australian biomedical and medical technology innovations.
2025-07
Therapeutic Goods Administration (TGA)
AI-enabled medical devices in the ARTG - Therapeutic Goods Administration (TGA)
This TGA article discusses AI-enabled medical devices listed in the Australian Register of Therapeutic Goods (ARTG), providing examples and regulatory context for these technologies.
2026-04

Frequently Asked Questions

Diacoustic Medical Devices (Pty) offers the Sensicardiac Mobi and the Sensicardiac Mobi Diagnostic Heart Murmur Application. These products are electronic stethoscopes designed to aid in the detection and diagnosis of heart murmurs.
The 'Sensicardiac Mobi Diagnostic Heart Murmur Application' strongly indicates the integration of AI for diagnostic support in heart murmur detection. This AI-powered approach aims to enhance the accuracy and efficiency of identifying cardiac abnormalities during auscultation.
While specific integration partnerships are not publicly detailed for Diacoustic Medical Devices (Pty), their electronic stethoscope and diagnostic application are inherently suited for telemedicine and virtual care. Such digital health tools are crucial for remote patient monitoring and consultations, allowing for the sharing of heart sound data with remote providers.
Diacoustic Medical Devices (Pty) Ltd has received FDA 510(k) Premarket Notification for its SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION, indicating clearance for marketing in the United States. This demonstrates adherence to significant regulatory standards for medical devices.
While specific clinical study results for Diacoustic Medical Devices (Pty)'s products are not readily available in public search results, FDA 510(k) clearance typically requires demonstrating substantial equivalence to a legally marketed device. The effectiveness of digital stethoscopes in improving diagnostic accuracy for heart murmurs is a recognized area of research in the broader medical device industry.
Publicly available information on the specific pricing models for Diacoustic Medical Devices (Pty)'s products is not available. Generally, medical device companies offer various pricing structures and provide ongoing support including technical assistance, training, and software updates to ensure optimal device performance and clinical utility.
While specific details regarding Diacoustic Medical Devices (Pty)'s data privacy and security protocols are not publicly disclosed, medical devices cleared for market, especially those handling sensitive patient data, are expected to comply with stringent regulations like HIPAA and GDPR. This includes secure data transmission, storage, and access controls to protect patient health information.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.